Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rhabdomyosarcoma. A new classification scheme related to prognosis.

M Tsokos1, B L Webber, D M Parham

  • 1Laboratory of Pathology, National Institutes of Health, Bethesda, MD 20895.

Archives of Pathology & Laboratory Medicine
|August 1, 1992
PubMed
Summary

The National Cancer Institute (NCI) classification scheme improves rhabdomyosarcoma (RMS) prognosis prediction. Expanding the alveolar RMS category to include solid round-cell RMS enhances its prognostic value.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experts and performance in histopathology--a study in breast pathology.

Pathology, research and practice·2010
Same author

External quality assessment slide schemes: pathologists' experiences and perceptions.

Journal of clinical pathology·2006
Same author

The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal.

Journal of clinical pathology·2006
Same author

Are external quality assurance (EQA) slide schemes a valid tool for the performance assessment of histopathologists?

Pathology, research and practice·2005
Same author

Part-of relations in anatomy ontologies: a proposal for RDFS and OWL formalisations.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2004
Same author

Axillary lymph node scarring and the association with tumour response following neoadjuvant chemoendocrine therapy for breast cancer.

Breast (Edinburgh, Scotland)·2004

Area of Science:

  • Oncology
  • Pathology
  • Cancer Research

Background:

  • Rhabdomyosarcoma (RMS) classification impacts patient prognosis.
  • Existing World Health Organization (WHO) and National Cancer Institute (NCI) schemes have limitations.

Purpose of the Study:

  • To compare the prognostic value of WHO and NCI classification schemes for RMS.
  • To evaluate the NCI scheme's modification of including solid round-cell RMS in the alveolar category.

Main Methods:

  • Classified 159 RMS cases using WHO and modified NCI schemes.
  • Constructed survival curves using Kaplan-Meier method.
  • Compared prognostic values using Mantel-Haenszel and Cox regression analyses.

Main Results:

Related Experiment Videos

  • Both schemes showed prognostic value in unstratified analyses.
  • The NCI scheme demonstrated prognostic value in stratified analyses and Cox regression.
  • Solid round-cell RMS, previously classified as embryonal, shares features with alveolar RMS.

    • Conclusions:

    • The NCI classification scheme is a highly predictive, independent prognostic factor for RMS.
    • The alveolar RMS category should be expanded to include solid round-cell RMS, irrespective of architecture.
    • This revised classification improves prognostic accuracy in rhabdomyosarcoma.